Michael Scolaro

Michael Scolaro

Sep 19, 2017

Group 6 Copy 160
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    How can we create culturally competent workplaces for Muslim healthcare providers?

    Muslim healthcare providers constitute a growing, diverse and underrepresented population in the U.S. Culturally...

    Managing Congenital Adrenal Hyperplasia in the Amish Population

    Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...

    Backer Badge Funded